Take Part in the Third Era of Medicine
- First to market: NextGen sequencing based mitochondrial diseases diagnostic tests
- Good connections with clinicians and scientists in Mi IDEA community
- Extensive proprietary knowledge base of Mi IDEA diseases and associated genome variations
- IP in proprietary bioinformatics pipeline and unparalleled expert interpretation. Patentable.
- Most comprehensive testing for each of the 4 Mi IDEA diseases
Future: additional diseases, globalization and mass-consumer food product
Why Invest in MEDomics?
- Leader in a rapidly-growing huge market
- Unique methods & IP with durable competitive advantages
- Field-proven products and services
- Led by seasoned pioneers in genostics/pMED
